{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-089587","form_type":"8-K","ticker":"FLGT","cik":"0001674930","company_name":"Fulgent Genetics, Inc.","filed_at":"2024-08-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.060370+00:00","generated_at":"2026-05-31T13:28:40.883253+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Fulgent Q2 core revenue $70.2M (+5% YoY); GAAP loss $0.29/share improves EPS guidance","bullets":["Total revenue $71.0M; core revenue $70.2M (+5% YoY).","GAAP net loss $8.7M ($0.29 per share); Non-GAAP income $4.7M ($0.15 per share).","Adjusted EBITDA loss $727K; cash from ops $4.3M; cash and investments $837.9M.","Reiterates FY2024 core revenue guidance $280M; improves EPS guidance."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-089587","json":"https://secwatch.observer/filing/0000950170-24-089587.json","markdown":"https://secwatch.observer/filing/0000950170-24-089587.md","text":"https://secwatch.observer/filing/0000950170-24-089587.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1674930/000095017024089587/0000950170-24-089587-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1674930/000095017024089587/flgt-20240802.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T13:28:40.883253+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}